Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Borylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel iodination route for Crisaborole key intermediate reduces EHS risks and improves yield. Ideal for reliable pharmaceutical intermediate supplier partnerships.
Novel palladium-catalyzed route ensures high purity pharmaceutical intermediates with streamlined supply chain reliability and reduced manufacturing complexity for global buyers.
Patent CN114516779A details site-selective bromination and borylation of DHR, enabling cost reduction in electronic chemical manufacturing and scalable OLED intermediate production.
Patent CN106946923A reveals a transition-metal-free synthesis route for 1,2-diboron compounds, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103626791A details a cost-effective synthesis of 3-amino-4-fluorophenylboronic acid via Grignard borylation, offering significant supply chain advantages for pharmaceutical intermediates.
Patent CN114853794A details a high-yield synthesis of BN-NP, a novel perylene derivative for organic optoelectronics, offering cost-effective manufacturing solutions.
Novel copper-catalyzed route for high-purity tetrahydropyridine boronates offers significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Patent CN113416196B reveals novel benzothiadiazole-TB derivatives with large Stokes shifts for OLED materials and Fe3+ sensing, offering scalable synthesis routes.
Patent CN103030656B details a novel catalytic route for bortezomib, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN103044467A details a scalable route for R-(1-amino-3-methyl)butyl pinacol borate, eliminating cryogenic conditions and column chromatography for cost-effective manufacturing.
Patent CN108912157A details efficient borazaarenes synthesis for OLEDs. Offers supply chain stability and cost reduction in electronic chemical manufacturing for global partners.
Patent CN112409399B reveals a scalable 3-step synthesis for T541-D, offering high purity and cost reduction in API manufacturing for mTOR inhibitors.
Patent CN115894542B reveals a novel one-step synthesis for high-purity OLED intermediates. This method offers significant cost reduction and scalable supply chain reliability for electronic chemical manufacturing.
Novel Rh-catalyzed borylation method for high-purity pharmaceutical intermediates. Reduces cost and improves supply chain reliability for complex chiral building blocks.
Patent CN105566367B details a palladium-free synthesis route for high-purity intermediates. This method offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Patent CN102659919A details a cost-effective bortezomib synthesis using (R)-tert-butylsulfinamide, offering high purity and scalable manufacturing for global supply chains.
Patent CN115894349A reveals a novel borylation-fluorination route for 2,3-difluoro-5-chloropyridine, offering high purity and cost reduction in agrochemical manufacturing.
Patent CN104725409A reveals novel iridium catalysis for high-purity aryl borate. Enables cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN112442060B enables mild copper catalysis for gamma-aminoboronic acid esters. Achieve high purity pharmaceutical intermediates with reduced operational complexity and enhanced supply reliability.
Patent CN103626791B details a cost-effective Grignard route for high-purity 3-amino-4-fluorophenylboronic acid, offering supply chain stability and reduced manufacturing costs.